$631 Million is the total value of Rhenman & Partners Asset Management AB's 104 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CAT | Exit | Caterpillar Inc | $0 | – | -1,548 | -100.0% | -0.03% | – |
| MD | Exit | Mednax Inc | $0 | – | -9,000 | -100.0% | -0.12% | – |
| ILMN | Exit | Illumina Inc | $0 | – | -15,000 | -100.0% | -0.37% | – |
| PRGO | Exit | Perrigo Co Plc | $0 | – | -25,000 | -100.0% | -0.40% | – |
| Exit | NeuroDerm Ltd | $0 | – | -142,546 | -100.0% | -0.61% | – | |
| LIVN | Exit | Livanova Plc | $0 | – | -80,000 | -100.0% | -0.69% | – |
| ZLTQ | Exit | ZELTIQ Aesthetics Inc | $0 | – | -125,000 | -100.0% | -1.04% | – |
| ARIA | Exit | Ariad Pharmaceuticals Inc | $0 | – | -895,000 | -100.0% | -2.13% | – |
| TEVA | Exit | Teva Pharma Ind Ltd ADR repr 1 Share | $0 | – | -360,000 | -100.0% | -2.50% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-04-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.